Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis
- 1 April 1994
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 86 (4) , 887-889
- https://doi.org/10.1111/j.1365-2141.1994.tb04851.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Acute Myeloid Leukemia After Single-Agent Treatment with Etoposide for Langerhansʼ Cell Histiocytosis of BoneJournal of Pediatric Hematology/Oncology, 1993
- High Frequency of Etoposide (VP-16)-Related Secondary Leukemia in Children with Non-Hodgkinʼs LymphomaJournal of Pediatric Hematology/Oncology, 1993
- Association of langerhans cell histiocytosis with malignant neoplasmsCancer, 1993
- Langerhans cell histiocytosis and acute leukemia: Unusual association in two casesMedical and Pediatric Oncology, 1993
- Treatment of Langerhans Cell Histiocytosis in Children with EtoposideAmerican Journal of Clinical Oncology, 1992
- Therapy-related acute promyelocytic leukemia: a report on 16 cases.Journal of Clinical Oncology, 1992
- Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1991
- Etoposide (VP16) in the treatment of multisystem langerhans cell histiocytosis (histiocytosis X)Medical and Pediatric Oncology, 1989
- Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lungBlood, 1987
- Etoposide (VP-16–213)New England Journal of Medicine, 1985